lead plaintiff deadline

Rosen Law Firm urges Nektar investors to join securities class action alleging false statements about REZOLVE-AA trial enrollment. Deadline: May 5, 2026.

Hercules Capital faces securities class action alleging false statements on due diligence, valuations, and investment classification between May 2025 and February 2026.

Rosen Law Firm files securities class action against Eos Energy Enterprises ($EOSE) alleging false statements. May 5, 2026 lead plaintiff deadline for affected investors.

Rosen Law Firm files securities class action against biopharmaceutical company Aldeyra Therapeutics, alleging false statements. Lead plaintiff deadline: May 29, 2026.

Soleno Therapeutics faces securities litigation alleging undisclosed DCCR safety risks during March-November 2025. Lead plaintiff deadline: May 5, 2026.

Rosen Law Firm notifies $IT investors of ongoing securities class action against Gartner alleging false statements about growth rates and contract targets. Lead plaintiff deadline approaching.

Rosen Law Firm urges $STLA investors to join securities lawsuit alleging false statements about earnings and electrification strategy. Deadline set for June 8, 2026.

Super Micro Computer faces federal charges for illegally diverting $2.5B in servers to China. Stock plummeted 33.3% after March indictment. Investors must join lawsuit by May 25, 2026.

Pomerantz Law Firm filed securities fraud lawsuit against $AQST after FDA rejected Anaphylm NDA, triggering 37% stock drop. Investor deadline May 4.

Pomerantz Law Firm files class action lawsuit against $CORT after FDA rejection of relacorilant causes 50.4% stock decline. Investors urged to act by April 21, 2026 deadline.

Boston Scientific faces class action lawsuit after 17.6% stock drop from weaker-than-expected electrophysiology sales; investors have until May 4, 2026 to join.

Boston Scientific faces securities fraud lawsuit over undisclosed EP segment weakness, triggering 17.6% stock decline and May 4 lead plaintiff deadline.

Law Offices of Howard G. Smith seeks lead plaintiffs in securities fraud cases against $CHOW, $GO, $ALIT, $IT before mid-May 2026 deadline.

Law Offices of Howard G. Smith initiates securities fraud class actions against $PINS, $NUAI, $GOSS, and $MEDP; investors have until May-June 2026 deadline for lead plaintiff motions.

Atara Biotherapeutics stock collapsed 97% across two FDA rejections for tabelecleucel. Class action deadline: May 22, 2026.

Class action lawsuit filed against Grocery Outlet ($GO) alleging securities fraud, false financial statements, and unsustainable expansion strategy from August 2025-March 2026.

Securities class action filed against $PINS over alleged false statements on ad revenues, tariff impacts, and undisclosed restructuring plans. Investors have until May 29, 2026 deadline.

Rosen Law Firm alerts investors in $CWH securities to May 11 deadline in class action alleging false inventory management statements and overstated demand.

Rosen Law Firm alerts AQST investors of May 4, 2026 deadline to join class action alleging Aquestive Therapeutics concealed human factors issues with its Anaphylm drug application.

Rosen Law Firm alerts $ODD investors of securities class action lawsuit alleging false statements about advertising partner algorithm changes affecting financial strength.